Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplin… pubmed.ncbi.nlm.nih.gov/38771067/ Our fearless leader: kym watt All GU-related darts should be thrown at Talal M Al-Qaoud, Piyush Kumar Agarwal, and moi

New Obesity Drugs Lead to Excessive Muscle Loss? “The recent concern that marked weight loss induced by GLP-1–based anti-obesity medications can cause physical frailty or sarcopenia is not supported by data.” Amazing insights if you just interpret evidence and not sentiment. 👍🏻

EASLnews May we suggest some reading for the #EASLcongress on the future of MASH? nature.com/articles/s4157… Out today in Nature Reviews Gastroenterology & Hepatology Alina Allen Mayo Clinic Gastroenterology & Hepatology AASLD

📢 Discover the new EASL-EASD-EASO CPGs on MASLD now in the #EASLGuidelines App! 📲 Keep them always in your pocket & provide best practices and care to patients! Get the app on Apple Store! apps.apple.com/us/app/easl-gu… Journal of Hepatology JHEP Reports EASLnews EASO EASD

What is “NICER” than “Anticipate”? data on spleen stiffness in predicting CSPH Mattias Mandorfer The Baveno Cooperation: an EASL Consortium EASLnews #EASLCongress

Retatrutide (GLP1R-GIPR-GCGR triagonist) Ph2a MaSLD Trial: Normalization of liver fat content (<5%) @ 48 wks: 8 mg —> 89% 12 mg —> 93% Weight loss @ 48 wks 8 mg—> -23.8% 12 mg—> -25.9% TLDR: Retatrutide absolutely obliterates ectopic fat depots and reverses MaSLD in most. 🔥

Every year, hundreds of thousands of patients receive care at London Health Sciences Centre. Donor funding is essential to continue providing timely, efficient care. Make a difference by donating today: bit.ly/4bEsCrO

Weight Loss Medications For Obesity Have Changed Everything. The pace of change is incredible. But with staggering weight reductions, there are some downsides. 📕Make Sure To Book Mark✅ 🧵👇 /1

📢#livertwitter friends! The 2025 ILTS Congress will be in sensational Singapore🇸🇬 VisitSingapore US - get ready for an exciting 4 days celebrating quality liver research🥼🧪, education 📚and enriching culture! Juan Pablo (JP) Arab, MD  Manhal Izzy kym watt Varia Kirchner Ryan Chadha

Proud to be part of London Health Sciences Centre’s Multi Organ Transplant Program who recently performed Canada’s 🇨🇦FIRST normothermic regional perfusion-salvaged DCD Liver Transplant! Another win 🥇 for our patients! Mayur Brahmania MD Juan Pablo (JP) Arab, MD  Huma Saeed lfpress.com/news/local-new…

New Rx for AAT LD American Gastroenterological Association (AGA) AASLD EASLnews INASL Gastroenterology UCSD Gastroenterology Fazirsiran for Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOI… pubmed.ncbi.nlm.nih.gov/38964420/

New Review - Elkrief et al - Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies thelancet.com/journals/langa… ERN RARE LIVER Valdig Group #LiverTwitter Rautou Pierre-Emmanuel

MASH-related cirrhosis has its own particularities. How to design clinical trials in these patients ? We defined key end-points and guide the study design. Read this consensus statement in Nature Reviews Gastroenterology & Hepatology organized by LiverUnit_VallHebron. t.ly/UZ8tY Asociación Española para el Estudio del Hígado EASL Education

I am very grateful to have been able to collaborate in this The Lancet Seminar on Acute Liver Failure with Rakhi Maiwall Anand V Kulkarni Salvatore Piano Very important topic, hope you find it useful and informative 👉 Acute liver failure (ALF) is a life-threatening disorder

🎉From humble beginnings in rural Punjab, Arshad Nadeem has won the ❤️ of millions with 🇵🇰’s FIRST-ever Olympic athletics medal and that too pure 🥇GOLD! 1st for the country in over 3 decades! A wonderful underdog story of persistence, self-belief and passion! Take a bow!👏🏼👏🏼

🆕Article in press❕ Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome Read it here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

Critical review alert 🚨🚨🚨 Cirrhotic cardiomyopathy and future directions Led by Dr. Cirrhotic cardiomyopathy himself - Manhal Izzy journals.lww.com/lt/abstract/99…

Less=More w #antibiotics in #cirrhosis & ✅ reconsider #SecSBPProphylaxis AJG - The American Journal of Gastroenterology⤵️ pubmed.ncbi.nlm.nih.gov/39235290/ 🔑#SecSBPPr vs others▶️⬆️SBP recurrence &🚫mortality benefit 🔑2 datasets (VA Research & TriNetX) w similar trends 🔑worsens over time & validated locally Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟